DAYBREAK Trademark

Trademark Overview


On Monday, October 10, 2016, a trademark application was filed for DAYBREAK with the United States Patent and Trademark Office. The USPTO has given the DAYBREAK trademark a serial number of 87197710. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, February 2, 2024. This trademark is owned by H. Lundbeck A/S. The DAYBREAK trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorder, stroke, depression, cognitive, mood disorders, psychosis, anxiety, epilepsy, sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, ADHD, cancer, pain, alcoholism and chemical dependency; diagnostic agents, reagents, preparations and substances for medical purposes

Scientific and technological services, namely, research and design relating thereto in the field of science, medicine and pharmaceuticals regarding the treatment of schizophrenia; conducting clinical studies, tests and trials for others in the fields of science, medicine and pharmaceuticals regarding the treatment of schizophrenia; industrial analysis and research services in the field of science, medicine and pharmaceuticals regarding the treatment of schizophrenia; pharmaceutical and medical research and development regarding the treatment of schizophrenia; medical and clinical and diagnostic research, studies, tests and trials in the field of science, medicine and pharmaceuticals regarding the treatment of schizophrenia and providing information in the field of research and development of pharmaceuticals for the treatment of schizophrenia
daybreak

General Information


Serial Number87197710
Word MarkDAYBREAK
Filing DateMonday, October 10, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, February 2, 2024
Registration Number5244577
Registration DateTuesday, July 18, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 2, 2017

Trademark Statements


Goods and ServicesVaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorder, stroke, depression, cognitive, mood disorders, psychosis, anxiety, epilepsy, sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, schizophrenia, bipolar disorder and disease, ADHD, cancer, pain, alcoholism and chemical dependency; diagnostic agents, reagents, preparations and substances for medical purposes
Goods and ServicesScientific and technological services, namely, research and design relating thereto in the field of science, medicine and pharmaceuticals regarding the treatment of schizophrenia; conducting clinical studies, tests and trials for others in the fields of science, medicine and pharmaceuticals regarding the treatment of schizophrenia; industrial analysis and research services in the field of science, medicine and pharmaceuticals regarding the treatment of schizophrenia; pharmaceutical and medical research and development regarding the treatment of schizophrenia; medical and clinical and diagnostic research, studies, tests and trials in the field of science, medicine and pharmaceuticals regarding the treatment of schizophrenia and providing information in the field of research and development of pharmaceuticals for the treatment of schizophrenia

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 2, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, February 2, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameH. Lundbeck A/S
Party Type30 - Original Registrant
Legal Entity Type99 - Other
Address2500 Valby
DK

Party NameH. Lundbeck A/S
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
Address2500 Valby
DK

Party NameH. Lundbeck A/S
Party Type10 - Original Applicant
Legal Entity Type99 - Other
Address2500 Valby
DK

Trademark Events


Event DateEvent Description
Friday, February 2, 2024CANCELLED SEC. 8 (6-YR)
Monday, July 18, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, July 18, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, May 2, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 2, 2017PUBLISHED FOR OPPOSITION
Wednesday, April 12, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 27, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, March 15, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 23, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 23, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, February 12, 2017ASSIGNED TO LIE
Monday, January 30, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 20, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 20, 2016NON-FINAL ACTION E-MAILED
Tuesday, December 20, 2016NON-FINAL ACTION WRITTEN
Monday, December 19, 2016ASSIGNED TO EXAMINER
Friday, October 14, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 13, 2016NEW APPLICATION ENTERED